Ekso Bionics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $5,090 | $4,129 | $4,950 | $3,756 |
Gross Profit | 2,714 | 2,209 | 2,637 | 1,951 |
EBITDA | -2,956 | -1,586 | -1,945 | -2,966 |
EBIT | -3,354 | -1,993 | -2,342 | -3,372 |
Net Income | -3,413 | -2,072 | -2,416 | -3,429 |
Net Change In Cash | 5,090 | 4,129 | 4,950 | 3,756 |
Free Cash Flow | -1,454 | -2,285 | -2,670 | -3,474 |
Cash | 6,493 | 8,292 | 5,885 | 8,799 |
Basic Shares | 20,161 | 20,310 | 18,224 | 17,419 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $17,925 | $18,279 | $12,912 | $11,246 |
Gross Profit | 9,511 | 9,079 | 6,214 | 6,749 |
EBITDA | -9,453 | -13,198 | -14,037 | -9,090 |
EBIT | -11,061 | -14,896 | -14,924 | -9,651 |
Net Income | -11,330 | -15,198 | -14,604 | -8,432 |
Net Change In Cash | 17,925 | 18,279 | 12,912 | 11,246 |
Free Cash Flow | -9,846 | -12,211 | -14,882 | -11,215 |
Cash | 6,493 | 8,638 | 20,525 | 40,406 |
Basic Shares | 20,161 | 13,867 | 12,962 | 12,269 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.14 |
2024-09-30 | -$0.10 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.20 |
